News

Wednesday October 16, 2019

16 Oct 2019 – Positive Phase 1 results published in journal

Destiny Pharma plc (“Destiny Pharma” or the “Company”) Positive results published from an independent (US National Institute of Health) XF-73 phase 1 clinical trial in a peer reviewed journal The […]